Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-006294
Filing Date
2025-03-05
Accepted
2025-03-05 16:05:01
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1342
  Complete submission text file 0001437749-25-006294.txt   2725
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22616 ERWIN STREET WOODLAND HILLS CA 91367
Business Address
Vu Quan Anh (Reporting) CIK: 0001892297 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39070 | Film No.: 25710846